Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

indolent lymphoma

Known as: Non-Hodgkin lymphoma, indolent, NOS, Indolent Non-Hodgkin's Lymphoma, indolent lymphomas 
A non-Hodgkin lymphoma with an indolent clinical course. Representative examples include grade 1 and grade 2 follicular lymphoma, marginal zone… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Purpose Phosphatidylinositol 3-kinase (PI3K) signaling is critical for the proliferation and survival of malignant B cells… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
PURPOSE T cells can be genetically modified to express an anti-CD19 chimeric antigen receptor (CAR). We assessed the safety and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Tumor regression after antiviral therapy (AT) is in favor of an etiological role of hepatitis C virus (HCV) in non… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2011
Review
2011
Histologic transformation (HT) to an aggressive lymphoma is a well-described event in the natural history and clinical course of… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Review
2009
Review
2009
PET with 18F-FDG is a standard staging procedure for most lymphoma subtypes. Performed during and after therapy for Hodgkin… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Positron emission tomography using 18F-fluorodeoxyglucose (FDG-PET) has been successfully evaluated in the management of non… Expand
  • table 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE (18)Fluorodeoxyglucose positron emission tomography (FDG PET) is widely used for the staging of lymphoma. We investigated… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE To evaluate response to single-agent rituximab in patients with indolent non-Hodgkin's lymphoma (NHL) and no previous… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The incidence of indolent lymphomas in the lymph nodes and extranodal regions is quite different. Follicular lymphoma (FL) is… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Patients with advanced indolent lymphoma often have long survival (median, 4 to 8 years) in spite of frequent relapses. The… Expand
Is this relevant?